July 2012
Welcome Edition
Welcome
to the inaugural issue of a new monthly publication, the Funding Flash.
Building upon the monthly reports already provided by the Office of
Sponsored Research, this publication's goal is to provide you with a useful tool for
identifying upcoming funding opportunities, including more opportunities
from non-traditional sources such as foundations. Every month, we
aim to provide a list of open opportunities at least 90 days out.At the recent strategic retreats, it became very clear that Moffitt must provide better assistance in finding funding opportunities in this challenging grant environment.
The funding opportunities, summarized below, are organized by due date and include links to the sponsor website. We hope these tools help you find more opportunities in less time.
We also recognize a monthly email cannot meet all of your needs. In addition to this publication, we have developed a Funding Opportunities Calendar to provide you with another way to search funding opportunities. We have also begun posting these opportunities on the digital signs next to the elevators. We continue to work on improving all of these tools and seeking out more opportunities, including from foundations and other non-traditional sources. An improved website that will make it easier to find other important grant information is also in development.
As always, you feedback is important.
Thank you,
Michael Benedict, PharmD
Vice President for Research
 |
National Comprehensive Cancer Network (NCCN) RFP NCCN is pleased to announce that is has received a research grant from AVEO Pharmaceuticals, Inc. and Astrellas Pharmaceuticals, Inc. to support NCCN investigator initiated clinical studies in the treatment of specific solid tumors. For additional information please contact Doreen Walker, Administrative Assistant, Oncology Research Program, at (215) 690-0565 or via email at Walker@nccn.org. RFP | NCCN.org |
||||||||||||||||
|
|
|||||||||||||||||
 |
Flight Attendant
Medical Research Institute:
There are 2 Program Opportunities on the topic of second hand tobacco smoke and smoking-related disorders
|
||||||||||||||||
|
|
|||||||||||||||||
 |
Harrington Scholar-Innovator Grants
The UH Harrington Discovery Institute (HDI) is dedicated to physician-scientists, enabling them to transform their extensive, cross-cutting
knowledge into therapies and medicines that improve patients'
lives. The new Scholar-Innovator Program is a grant competition
that serves as a nationwide search for physician-scientists
seeking support to accelerate their promising drug discoveries
into novel treatments for patients. Designed to support the
translation of research from laboratory to early development
stages, the annual grant competition will support up to 10
physician-scientists each year.
RFA | Harrington Discovery Institute |
||||||||||||||||
|
|
|||||||||||||||||
 |
ACS Clinical Research Professor
Mid-career investigators who have made seminal contributions in the area of cancer control that have changed the direction of clinical, psychosocial, behavioral, health policy or epidemiologic cancer research.
|
||||||||||||||||
|
|
|||||||||||||||||
 |
Smoking Cessation Leadership Center at UCSF and Pfizer Medical Education Group The Smoking Cessation Leadership Center (SCLC) at the University of California in San Francisco and the Pfizer Medical Education Group are collaborating to offer a new grant opportunity focused on smoking cessation. There are three categories of focus for which grant support is available for one year.
|
||||||||||||||||
|
|
|||||||||||||||||
|
NIH Multidisciplinary Studies of HIV/AIDS & Aging (& Cancer)
Funding opportunities in HIV infection, its associated conditions, treatment, and/or biobehavioral or social factors in the context of aging and/or in older adults.
Research approaches include clinical translational, observational, and intervention studies in domestic and international settings. Scope includes numerous cancer related topics (infection- and non-infection-related):
|
||||||||||||||||
|
|
|||||||||||||||||
|
Ruth L. Kirschstein National Research Service Awards (NRSA) for Individual Postdoctoral Fellows
This individual postdoctoral research training fellowship provides support to promising Fellowship Applicants with the potential to become productive, independent investigators in scientific health-related research fields.
PA-11-113 | NRSA Site | Stipend Levels |
||||||||||||||||
|
|
|||||||||||||||||
|
Minority-Based Community Clinical Oncology Program Groups (U10) Grant
The purpose of this program is to support research activities of physicians involved in the care of minorities who are eligible to participate in NCI-sponsored cancer prevention, control, and treatment clinical trials.
RFA-CA-12-008 |
||||||||||||||||
|
|
|||||||||||||||||
 |
Department of Defense
This Concept Award mechanism supports the exploration of a highly innovative new concept or untested theory that addresses an important problem relevant to lung cancer.
|
||||||||||||||||
|
|
|||||||||||||||||
|
The National Institute of Biomedical Imaging & Bioengineering (NIBIB)
Decreasing Patient Radiation Dose from CT Imaging:
Research leading to reduction of patient radiation exposure from a CT scan.
|
||||||||||||||||
|
|
|||||||||||||||||
|
Pre-application for the NIH-Industry Pilot Program: Discovering New Therapeutic Uses for Existing Molecules The National Center for Advancing Translational Sciences (NCATS) seeks to develop a therapeutics discovery pilot program to explore new therapeutic uses for proprietary drug candidates across a broad range of human diseases. This innovative program will match Agents and associated data from pharmaceutical company partners with the best ideas for new therapeutic uses from the biomedical research community.
The X02 pre-application is the first step in the application
process for
RFA-TR-12-004 and
RFA-TR-12-005; applicants must read both of the companion
FOAs.
|
||||||||||||||||
|
|
|||||||||||||||||
|
NHLBI Systems Biology Collaborations
Collaborative systems biology research projects by multi-disciplinary teams to advance our understanding of normal physiology and perturbations associated with heart, lung, blood, and sleep (HLBS) diseases and disorders. Multi-disciplinary expertise across experimental and computational domains is required, and the multi-PI mechanism is allowed, as integration across these domains is a critical element of the proposed research plan.
|
||||||||||||||||
|
|
|||||||||||||||||
 |
The Hirshberg Foundation for Pancreatic Cancer Research Pancreatic Cancer Research Seed Grant Award Program
To provide start-up funding for basic scientists and clinicians to test innovative ideas for improving diagnosis and develop new treatment for pancreatic cancer.
|
||||||||||||||||
|
|
|||||||||||||||||
 |
Uniting Against Lung Cancer (UALC) UALC is dedicated to bringing new researchers into the field of lung cancer. In addition to funding the highest quality science, we have prioritized providing start-up funds for early-career investigators to build the foundation for a lung cancer research program. Collaborations with industry partners are also strongly encouraged; however the Principal Investigator is required to be an academic researcher. Due Date: August 15, 2012
RFA | Uniting Against Lung Cancer |
||||||||||||||||
|
|
|||||||||||||||||
 |
Air Force
Office of Scientific Research
The
Young Investigator Research Program (YIP)
supports scientists and engineers in Air Force
relevant disciplines and is designed to promote
innovative research in science and engineering. |
||||||||||||||||
|
|
|||||||||||||||||
|
NIH U.S.-China Program for Biomedical Collaborative Research
To stimulate collaborative basic, translational, and applied research between United States (U.S.)-based researchers and Chinese researchers in the areas of allergy, immunology, and infectious diseases including HIV/AIDS and its co-morbidities and co-infections, cancer, mental health, Parkinson's disease (PD), and stroke.
|
||||||||||||||||
|
|
|||||||||||||||||
|
Validation and Advanced Development of Emerging Technologies for Cancer Research
Research projects on the advanced development of emerging molecular and cellular analysis technologies through technical/analytical validation in an appropriate cancer-relevant biological system or context. An emerging technology is defined as one that has passed the pilot developmental stage and shows promise, but has not yet been evaluated within the context of its intended use. If successful, these technologies would accelerate research in cancer biology, cancer treatment and diagnosis, cancer prevention, cancer control and epidemiology, and/or cancer health disparities. For projects where proof-of-principle of the proposed technology or methodology has been established and supportive preliminary data are available. Projects proposed to this FOA should reflect the potential to produce a major impact in a broad area of cancer-relevant research. Projects proposing to use established technologies where the novelty resides in the biological or clinical question being pursued are not appropriate for this solicitation as non-responsive and will not be reviewed.
|
||||||||||||||||
|
|
|||||||||||||||||
|
Early-Stage Innovative Technology Development for Cancer Research
Exploratory research projects focused on the inception and development of early stage, highly innovative, technologies or emerging technologies with significant transformative potential that has not yet been explored in a cancer-relevant use. An emerging technology is defined (for the purpose of this FOA) as one that has passed the initial developmental stage, but has not yet been evaluated within the context of a cancer-relevant intended use and requires significant modification for the proposed application. The emphasis of this FOA is on technologies with a high degree of technical innovation with the potential to significantly affect and transform investigations exploring the molecular and cellular bases of cancer. If successful, these technologies would accelerate and/or enhance research in the areas of cancer biology, prevention, diagnosis and treatment, control, epidemiology, and/or cancer health disparities. Technologies proposed for development may be intended to have widespread applicability but must be based on molecular and/or cellular characterizations of cancer.
|
||||||||||||||||
|
|
|||||||||||||||||
 |
2013 Young Investigator Research Grant The purpose of this Grant Program is to drive research forward that will increase understanding of lung cancer, while ensuring that young investigators have the resources needed for them to succeed as lung cancer researchers. Multiple grants are available in 2013. Basic, translational or clinical proposals are eligible for funding. Research that will lead to significant improvement in lung cancer prevention, detection, diagnosis, screening, treatment, and symptom management is sought.
RFA | National Lung Cancer Partnership |
||||||||||||||||
|
|
|||||||||||||||||
|
NIH Director's Transformative Research Awards
To support individual or groups of scientists proposing groundbreaking and/or unconventional research with the potential to create new scientific paradigms, establish improved clinical approaches, or develop transformative technologies. Little or no preliminary data are expected.
|
||||||||||||||||
|
|
|||||||||||||||||
 |
American Gastroenterological Association Research Foundation
Funderburg Research Award in Gastric Cancer
To support an established investigator in the field of gastric biology
whose research will enhance the fundamental
understanding of gastric cancer. AGA
membership is required. |
||||||||||||||||
|
|
|||||||||||||||||
 |
The Society of Nuclear Medicine
and Therapy
Provide support to a research scholar in an established molecular imaging lab that will apply molecular imaging approaches (including tool development) to investigate biological pathways in disease models.
|
||||||||||||||||
|
|
|||||||||||||||||
 |
Joint DMS/NIGMS Initiative to Support Research At the Interface of the Biological and Mathematical Sciences
The Division of Mathematical Sciences in the Directorate for Mathematical and Physical Sciences at the National Science Foundation and the National Institute of General Medical Sciences at the National Institutes of Health plan to support research in mathematics and statistics on questions in the biological and biomedical sciences.
|
||||||||||||||||
|
|
|||||||||||||||||
|
Short Courses on Mathematical, Statistical & Computational Tools for Studying Biological Systems (R25) This FOA encourages applications for Research Education Grants (R25) from institutions and organizations to conduct workshops and short courses to improve integration of mathematical, statistical, and computational approaches into biological and/or behavioral research. Support will be limited to activities that reach a wide audience of researchers. The FOA is not intended for university courses or curriculum development.
PA-110351 |
||||||||||||||||
|
|
|||||||||||||||||
 |
Personalized Oncology for Lung Cancer Patients Bonnie J. Addario Lung Cancer Foundation Personalized Oncology for Lung Cancer Patients as early as possible in their disease. This could include searching through any of the "-omics" for relevant markers or patterns of markers of specific and individual types of disease. At this time, most of our grants are designed to be "seed" funds for initiating innovative research work. We are looking at projects that have a stated direct and fairly immediate benefit for patients.
RFA | Flyer |
||||||||||||||||
|
|
|||||||||||||||||
|
|
ACS-IRG Fall 2012 Cycle 32 Moffitt Cancer Center, the University of South Florida and Ponce School of Medicine invite Junior Investigators to apply for an American Cancer Society Institutional Research Grant. This funding serves to support junior faculty initiating cancer related research projects to assist them in competing successfully for national research grants.
|
| Toolbox | ||
|
Funding Opportunities |
Grant Preparation |
Other |
| Clinical Research | ||
| NIH Standard Due Dates | ||
| Questions? MRISignals@moffitt.org |
 |